208 related articles for article (PubMed ID: 35282440)
21. Preoperative Levels of Catecholamines and Metanephrines and Intraoperative Hemodynamics of Patients Undergoing Pheochromocytoma and Paraganglioma Resection.
Weingarten TN; Welch TL; Moore TL; Walters GF; Whipple JL; Cavalcante A; Bancos I; Young WF; Gruber LM; Shah MZ; McKenzie TJ; Schroeder DR; Sprung J
Urology; 2017 Feb; 100():131-138. PubMed ID: 27769919
[TBL] [Abstract][Full Text] [Related]
22. Preoperative Metyrosine Improves Cardiovascular Outcomes for Patients Undergoing Surgery for Pheochromocytoma and Paraganglioma.
Wachtel H; Kennedy EH; Zaheer S; Bartlett EK; Fishbein L; Roses RE; Fraker DL; Cohen DL
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S646-54. PubMed ID: 26374407
[TBL] [Abstract][Full Text] [Related]
23. Pheochromocytoma and paraganglioma-an update on diagnosis, evaluation, and management.
Jain A; Baracco R; Kapur G
Pediatr Nephrol; 2020 Apr; 35(4):581-594. PubMed ID: 30603807
[TBL] [Abstract][Full Text] [Related]
24. Impact of body composition and genotype on haemodynamics during surgery for pheochromocytoma and paraganglioma.
Pang Y; Li M; Jiang J; Chen X; Fu Y; Wang C; He Y; Zhao Y; Wang Y; Guan X; Zhang L; Xu X; Gan Y; Liu Y; Xie Y; Tang T; Wang J; Xie B; Liang Z; Chen D; Liu H; Chen C; Eisenhofer G; Liu L; Yi X; Chen BT
J Cachexia Sarcopenia Muscle; 2022 Dec; 13(6):2843-2853. PubMed ID: 36068986
[TBL] [Abstract][Full Text] [Related]
25. To block, or not to block … is it still the question? Effectiveness of alpha- and beta-blockade in phaeochromocytoma surgery: an institutional analysis.
Van Den Heede K; Paspala A; Chander N; Chidambaram S; Wernig F; Todd JF; DiMarco AN; Palazzo FF
Ann R Coll Surg Engl; 2022 Feb; 104(2):138-143. PubMed ID: 34582296
[TBL] [Abstract][Full Text] [Related]
26. [Clinical profile of pheochromocytoma and paraganglioma with normal plasma free metanephrines].
Liu L; Tian J; Wu K; Gao Y; Zhang Z; Zhang JQ; Guo XH
Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Aug; 52(4):614-620. PubMed ID: 32773788
[TBL] [Abstract][Full Text] [Related]
27. High pre-operative urinary norepinephrine is an independent determinant of peri-operative hemodynamic instability in unilateral pheochromocytoma/paraganglioma removal.
Chang RY; Lang BH; Wong KP; Lo CY
World J Surg; 2014 Sep; 38(9):2317-23. PubMed ID: 24782037
[TBL] [Abstract][Full Text] [Related]
28. Factors contributing to development and resolution of dysglycemia in patients with pheochromocytomas and catecholamine-secreting paragangliomas.
Zhao L; Zhang T; Meng X; Zhang Z; Zhou Y; Fan H; Liu Y; Zhou X; Zhu H
Ann Med; 2023 Dec; 55(1):2203945. PubMed ID: 37129505
[TBL] [Abstract][Full Text] [Related]
29. Risk Factors for Cardiac Complications in Patients With Pheochromocytoma and Paraganglioma: A Retrospective Single-Center Study.
Zhao L; Meng X; Mei Q; Fan H; Liu Y; Zhou X; Zhu H; Zhang S
Front Endocrinol (Lausanne); 2022; 13():877341. PubMed ID: 35721724
[TBL] [Abstract][Full Text] [Related]
30. The diagnosis and management of pheochromocytoma and paraganglioma during pregnancy.
Clifton-Bligh RJ
Rev Endocr Metab Disord; 2023 Feb; 24(1):49-56. PubMed ID: 36637675
[TBL] [Abstract][Full Text] [Related]
31. Left Ventricular Structural and Functional Alterations in Patients With Pheochromocytoma/Paraganglioma Before and After Surgery.
Dobrowolski P; Januszewicz A; Klisiewicz A; Gosk-Przybyłek M; Pęczkowska M; Kabat M; Kwapiszewska A; Warchoł-Celińska E; Ambroziak U; Doroszko A; Toutounchi S; Gałązka Z; Bednarczuk T; Górnicka B; Januszewicz M; Hoffman P; Lenders JWM; Eisenhofer G; Prejbisz A
JACC Cardiovasc Imaging; 2020 Dec; 13(12):2498-2509. PubMed ID: 32950457
[TBL] [Abstract][Full Text] [Related]
32. Preoperative alpha-blockade in phaeochromocytoma and paraganglioma: is it always necessary?
Isaacs M; Lee P
Clin Endocrinol (Oxf); 2017 Mar; 86(3):309-314. PubMed ID: 27864838
[TBL] [Abstract][Full Text] [Related]
33. Diagnosis for Pheochromocytoma and Paraganglioma: A Joint Position Statement of the Korean Pheochromocytoma and Paraganglioma Task Force.
Ku EJ; Kim KJ; Kim JH; Kim MK; Ahn CH; Lee KA; Lee SH; Lee YB; Park KH; Choi YM; Hong N; Hong AR; Kang SW; Park BK; Seong MW; Kim M; Jung KC; Jung CK; Cho YS; Paeng JC; Kim JH; Ryu OH; Rhee Y; Kim CH; Lee EJ
Endocrinol Metab (Seoul); 2021 Apr; 36(2):322-338. PubMed ID: 33820394
[TBL] [Abstract][Full Text] [Related]
34. ERBB-2 overexpression as a risk factor for malignant phaeochromocytomas and paraganglinomas.
Wang W; Zhong X; Ye L; Qi Y; Su T; Wei Q; Xie J; Jiang L; Jiang Y; Zhou W; Cui B; Ning G
Clin Endocrinol (Oxf); 2016 Jun; 84(6):822-9. PubMed ID: 26749044
[TBL] [Abstract][Full Text] [Related]
35. Genetic Characteristics of Incidental Pheochromocytoma and Paraganglioma.
Zhang J; Li M; Pang Y; Wang C; Wu J; Cheng Z; Li X; Lu Z; Liu Y; Guo J; Chen X; He Y; Guan X; Xu X; Wang Y; Liu J; Guo W; Hou Y; Liu L; Jiang J; Gao X
J Clin Endocrinol Metab; 2022 Apr; 107(5):e1835-e1842. PubMed ID: 35106577
[TBL] [Abstract][Full Text] [Related]
36. Glycemic disorders in patients with pheochromocytomas and sympathetic paragangliomas.
Araujo-Castro M; Mínguez Ojeda C; García Centeno R; López-García MC; Lamas C; Hanzu FA; Mora M; Del Castillo Tous M; Rodríguez de Vera Gómez P; Parra Ramírez P; Alvarez-Escola C; Blanco Carrera C; Barahona San Millán R; Recasens M; Valdés N; Gracia Gimeno P; de Miguel Novoa P; Vicente A; Manjón L; García Sanz I; Michalopoulou T; Calatayud M
Endocr Relat Cancer; 2022 Dec; 29(12):645-655. PubMed ID: 36069783
[TBL] [Abstract][Full Text] [Related]
37. Approach to the Patient: Perioperative Management of the Patient with Pheochromocytoma or Sympathetic Paraganglioma.
Berends AMA; Kerstens MN; Lenders JWM; Timmers HJLM
J Clin Endocrinol Metab; 2020 Sep; 105(9):. PubMed ID: 32726444
[TBL] [Abstract][Full Text] [Related]
38. Update on Pheochromocytoma and Paraganglioma from the SSO Endocrine and Head and Neck Disease Site Working Group, Part 2 of 2: Perioperative Management and Outcomes of Pheochromocytoma and Paraganglioma.
Patel D; Phay JE; Yen TWF; Dickson PV; Wang TS; Garcia R; Yang AD; Kim LT; Solórzano CC
Ann Surg Oncol; 2020 May; 27(5):1338-1347. PubMed ID: 32112213
[TBL] [Abstract][Full Text] [Related]
39. Pheochromocytoma and paraganglioma: clinical feature-based disease probability in relation to catecholamine biochemistry and reason for disease suspicion.
Geroula A; Deutschbein T; Langton K; Masjkur J; Pamporaki C; Peitzsch M; Fliedner S; Timmers HJLM; Bornstein SR; Beuschlein F; Stell A; Januszewicz A; Prejbisz A; Fassnacht M; Lenders JWM; Eisenhofer G
Eur J Endocrinol; 2019 Oct; 181(4):409-420. PubMed ID: 31370000
[TBL] [Abstract][Full Text] [Related]
40. Abandonment of intravenous volume expansion after preoperative receipt of α-blockers in patients with adrenal pheochromocytoma was not an independent risk factor for intraoperative hemodynamic instability.
Yan KW; Tian XF; Wu YN; Cai M; Guo MT
Front Endocrinol (Lausanne); 2023; 14():1131564. PubMed ID: 37152944
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
